NASDAQ: AVXL
Anavex Life Sciences Corp Stock Ownership - Who owns Anavex Life Sciences?

Insider buying vs selling

Have Anavex Life Sciences Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Steffen ThomasDirector2025-06-0550,000$1.76
$88.00kBuy
Steffen ThomasDirector2025-06-0511,349$7.75
$87.95kSell
Christopher U. MisslingPresident and CEO2025-03-24500,000$0.92
$460.00kBuy
Christopher U. MisslingPresident and CEO2025-03-24282,497$9.63
$2.72MSell

1 of 1

AVXL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVXL insiders and whales buy or sell their stock.

AVXL Shareholders

What type of owners hold Anavex Life Sciences Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc7.85%6,703,623$74.95MInstitution
Vanguard Group Inc5.74%4,902,246$54.81MInstitution
State Street Corp3.77%3,214,256$35.94MInstitution
Geode Capital Management LLC2.30%1,964,810$21.97MInstitution
Christopher U. Missling1.72%1,467,713$16.41MInsider
Athanasios Skarpelos1.53%1,306,458$14.61MInsider
Nwam LLC1.17%1,000,351$11.18MInstitution
George Kalkanis1.05%900,000$10.06MInsider
Morgan Stanley1.01%864,728$9.67MInstitution
Two Sigma Investments LP1.01%860,098$9.62MInstitution

1 of 3

AVXL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVXL36.80%5.15%Net BuyingNet Buying
SYRE70.61%29.39%Net Selling
NRIX90.94%9.06%Net SellingNet Selling
MLYS61.25%38.75%Net BuyingNet Selling
SANA51.20%48.80%Net Selling

Anavex Life Sciences Stock Ownership FAQ

Who owns Anavex Life Sciences?

Anavex Life Sciences (NASDAQ: AVXL) is owned by 36.80% institutional shareholders, 5.15% Anavex Life Sciences insiders, and 58.04% retail investors. Christopher U. Missling is the largest individual Anavex Life Sciences shareholder, owning 1.47M shares representing 1.72% of the company. Christopher U. Missling's Anavex Life Sciences shares are currently valued at $16.31M.

If you're new to stock investing, here's how to buy Anavex Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.